Physician profile
Joseph J Repay
NPI 1215069059
$666.69
in general payments reported to CMS, 2019-2025
8 companies · $47.81 in 2025
The $47.81 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.29 · 2020: $72.23 · 2021: $13.89 · 2022: $176 · 2023: $309 · 2024: $33.37 · 2025: $47.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $176.44 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.88 | 2023-2024 | Jardiance, Synjardy |
| Edwards Lifesciences Corporation | $125.00 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $77.30 | 2019-2024 | Repatha, Otezla |
| Penumbra, INC. | $50.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $47.81 | 2025 | |
| Cleerly, INC. | $24.03 | 2023 | Cleerly Labs |
| Glaxosmithkline, LLC. | $22.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Repay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.